Merve Sumbul

Dr. Merve Sumbul

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2026 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
MSMerve Sumbul
Merve Sumbul
MEMehmet Can Erisen
Mehmet Can Erisen
BKBerçem Berent Kaya
Berçem Berent Kaya
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
RORamazan Azim Azim Okyay
Ramazan Azim Azim Okyay
BKBurhan Koçyiğit
Burhan Koçyiğit
Purpose: This study aims to investigate the effect of seasonal influenza vaccination on hospitalization rates among patients presenting to the emergency department with influenza-like illness. Methods: A retrospective, single-center observational study was conducted, involving adult patients with influenza (ICD-10 codes J10 and J11) diagnosed in the emergency department between May 2024 and April 2025. Clinical and demographic information was collected from electronic records, and vaccination status was confirmed through follow-up phone calls. To tackle the “zero event” problem—no hospitalizations among vaccinated individuals—advanced statistical modeling was employed, including standard logistic regression, and Bayesian logistic regression using Markov Chain Monte Carlo (MCMC) simulations. Odds ratios (OR) and 95% Highest Density Intervals (HDI) were calculated to assess the effectiveness of vaccination. Results: A total of 878 patients were enrolled: 3.3% ( n = 29) received vaccinations, while 2.7% ( n = 24) required hospitalization. None of the vaccine recipients were hospitalized. Standard logistic regression indicated that age was a significant indicator of hospitalization. Furthermore, Bayesian logistic regression followed, which confirmed vaccination’s statistically significant protective effect. The OR for vaccination was 0.526 (95% HDI: 0.336–0.739), indicating a 47% reduction in hospitalization risk among vaccinated individuals. Conclusion: Seasonal influenza vaccination was significantly associated with a lower risk of hospitalization in patients presenting with influenza-like illness to the emergency department. These findings support public health initiatives to enhance influenza vaccine coverage, particularly for the elderly.

22 April 2026
Verified
Book Chapter
Closed access
MSMerve Sumbul
Merve Sumbul
Aile Hekimliğinde Akut Hastalıkların Yön.Cilt:1-2

6 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
İAİRFAN ALİŞAN
İRFAN ALİŞAN
AMAhmet Gazi Mustan
Ahmet Gazi Mustan
BIBektas Isik
Bektas Isik
FAFatih Necip Arıcı
Fatih Necip Arıcı
CDCahit Dinçer
Cahit Dinçer
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
Background: Diabetic retinopathy (DR) is the most prevalent microvascular complication of type 2 diabetes mellitus (T2DM) and a recognised marker of systemic vascular injury. Whether DR—graded independently by two experienced ophthalmologists as part of routine institutional care—is independently associated with concurrent nephropathy (urine albumin-to-creatinine ratio [UACR] ≥ 30 mg/g) and subclinical cardiac stress (N-terminal pro-B-type natriuretic peptide [NT-proBNP] ≥ 125 pg/mL) remains insufficiently examined. Methods: Retrospective cross-sectional study of 401 T2DM adults who underwent dilated fundus examination independently graded by two board-certified ophthalmologists (each ≥ 10 years’ experience in diabetic eye disease) using ETDRS-based classification. Inter-physician agreement was quantified by Cohen’s weighted kappa. The primary composite outcome was concurrent nephropathy and subclinical cardiac stress. Multivariable logistic regression adjusted for age, sex, HbA1c, diabetes duration, eGFR, hypertension, and pharmacological treatments. Results: The composite outcome was present in 120 (64.2%) DR-positive vs. 14 (6.5%) DR-negative patients (crude OR: 25.59 (13.78–47.51); p < 0.001; fully adjusted OR: 21.49 (11.02–41.81); p < 0.001). Inter-physician agreement was high (Cohen’s weighted κ = 0.88; 95% CI: 0.83–0.93). Nephropathy alone was found in 164 (87.7%) vs. 76 (35.5%) patients (OR: 12.95 (7.71–21.75); p < 0.001), and elevated NT-proBNP in 137 (73.3%) vs. 39 (18.2%) patients (OR: 12.29 (7.65–19.76); p < 0.001). A significant trend across DR severity grades was observed (p for trend < 0.001), although the gradient was not strictly monotonic. ROC AUC = 0.837 (95% CI: 0.784–0.860). Conclusions: Ophthalmologist-graded DR was independently associated with the concurrent presence of albuminuria and elevated NT-proBNP in T2DM. Because the design is cross-sectional, these findings describe association rather than prediction or causation. They generate the hypothesis that retinal grading may help flag patients in whom cardiorenal biomarker assessment is worth considering, but prospective validation is required before any screening application.

22 April 2026
Verified
Book
Closed access
YAYasemin Özkan Aksungur
Yasemin Özkan Aksungur
BABeyza Akçal
Beyza Akçal
EAErsin Akpınar
Ersin Akpınar
CYCeyhun Yurtsever
Ceyhun Yurtsever
FCFatma Goksin Ci̇han
Fatma Goksin Ci̇han
NINizam İzZettin
Nizam İzZettin
Akut hastalık yönetimi, sağlık hizmetlerinin en kritik ve en hızlı karar verme gerektiren alanlarından biridir. Zamanla yarışılan bu süreçte doğru tanıya hızla ulaşmak, uygun tedaviyi başlatmak ve gerektiğinde doğru yönlendirmeyi yapmak, birinci basamak sağlık hizmetlerinin etkinliğini belirleyen temel unsurlardır. Aile Hekimliğinde Akut Hastalıkların Yönetimi, sahada karşılaşılan gerçek klinik gereksinimlerden doğmuş; sistematik, uygulanabilir ve güncel bir başvuru kaynağı olarak hazırlanmıştır. Aile hekimliği ilkeleri doğrultusunda yapılandırılan bu eser, akut hastalıklara yalnızca biyomedikal açıdan değil, biyopsikososyal ve kültürel boyutlarıyla bütüncül bir yaklaşım sunmaktadır. Kitap; ayrışmamış hastaya yaklaşım, hızlı ve doğru klinik karar verme, belirsizliklerin yönetimi ve sevk-izlem dengesi gibi birinci basamak pratiğinin temel zorluklarına rehberlik etmektedir. Aynı zamanda hasta merkezli bakım, etkili iletişim, etik ilkeler ve hasta güvenliği gibi modern tıbbın vazgeçilmez unsurlarını akut bakım süreçleriyle bütünleştirmektedir. Tele-tıp uygulamaları, dijital sağlık araçları ve elektronik sağlık kayıtları gibi güncel yaklaşımlar da eserde pratik bir perspektifle ele alınmaktadır. Klinik içerik açısından ise solunum, gastrointestinal, üriner ve genital, kas-iskelet, travmaya bağlı akut durumlar, kardiyovasküler, nörolojik, dermatolojik, göz, kulak, burun ve boğaz pediatrik, kadın sağlığı ve gebelik, geriatrik ve kırılgan popülasyon, psikiyatrik, metabolik ve endokrin, hematolojik, afetler ve olağanüstü durumlardaki tüm akut hastalıkları, kanıta dayalı ve sahada uygulanabilir bir çerçevede sunulmaktadır.

3 February 2026 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
IEIbrahim Erdem
Ibrahim Erdem
HOHuseyin Ali Ozturk
Huseyin Ali Ozturk
EGErdinc Gulumsek
Erdinc Gulumsek
FAFatih Necip Arici
Fatih Necip Arici
BAbegüm şeyda Avci
begüm şeyda Avci
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
In the our study, we examined the relationship between galectin-3 levels and global longitudinal strain (GLS) and aortic intima-media thickness (A-IMT) in

Verified
Journal Article
Open access
PDF file
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
BIBektas Isik
Bektas Isik
AMAhmet Gazi Mustan
Ahmet Gazi Mustan
İAİRFAN ALİŞAN
İRFAN ALİŞAN
CECigdem Erhan
Cigdem Erhan
MKMevlut Koc
Mevlut Koc
Background: Several studies have demonstrated that adding semaglutide to the treatment of patients with type 2 diabetes mellitus (T2DM) reduces insulin requirements and glycated hemoglobin (HbA1c) levels. This study aimed to investigate real-world evidence for the effects of semaglutide dose escalation on HbA1c, body weight, dyslipidemia, and insulin dose reduction in patients with T2DM in the Cukurova region of Türkiye. Methods: This retrospective cohort study enrolled 500 patients (255 male, 245 female; mean age 56.1 ± 10.8 years) who initiated semaglutide therapy for T2DM between 2024 and 2025. Patients were grouped according to their maximum semaglutide dose: 0.25 mg (Group I), 0.50 mg (Group II), and 1.00 mg (Group III). The primary endpoint was the change in HbA1c from baseline to end of study (30 weeks) across semaglutide dose escalation groups. Secondary endpoints included changes in body weight, frequency of insulin dose reduction, and effects on lipid parameters. Results: A total of 117 patients (23.4%) discontinued semaglutide therapy, while 383 patients (76.6%) completed the study. The primary endpoint revealed a mean HbA1c reduction of −1.03 ± 0.35% from baseline to end of study (95% CI 0.99–1.07; t = 58.644; p < 0.001). Reductions in HbA1c increased progressively from Group I to Group III (HbA1c: −0.72 ± 0.28, −1.02 ± 0.26, −1.27 ± 0.34%). Insulin dose reduction frequency increased significantly from Group I to Group III (40%, 41%, and 51%, respectively; p = 0.010), with a statistically significant difference only between Group I and Group III. At the end of follow-up, rates of hypoglycemic episodes and gastrointestinal (GI) adverse events were similar across groups. Conclusions: In a real-world population from the Cukurova region of Türkiye, semaglutide dose escalation in T2DM patients achieved clinically meaningful glycemic control, body weight reduction, LDL-cholesterol lowering, and a significant increase in insulin dose reduction frequency, without a significant increase in GI adverse events.